
Pictured clockwise from top left: Candace Fleischer, PhD, Homa Ghalei, PhD, Kimberly Hoang, MD, Kevin Kalinsky, MD, MS, Yong Teng, PhD, and Yong Wan, PhD
Six investigators will receive $300,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University.
Winship Invest$ is supported by philanthropic contributions and developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute. It has two funding cycles every year and solicits proposals in strategic research domains. The most recent call for proposals focused on projects related to precision immunotherapy, early detection, risk reduction and prevention, team science, neuro-oncology, breast cancer and general cancer research.
This cycle's Winship Invest$ pilot grant projects are below.
- Development of Ultrahigh Field Magnetic Resonance Methods to Image Glutamine for Applications in Gliomas
Candace Fleischer, PhD
Assistant professor, Department of Radiology and Imaging Sciences
Emory University School of Medicine - Towards Targeting snoRNAs in Lung Cancer
Homa Ghalei, PhD
Assistant professor, Department of Biochemistry
Emory University School of Medicine - Characterizing Complement Inhibition in Radiation Necrosis
Kimberly Hoang, MD
Assistant professor, Department of Neurosurgery
Emory University School of Medicine - Early Identification of Tumor Response in Patients with Breast Cancer Undergoing Immunotherapy and Chemotherapy
Kevin Kalinsky, MD, MS
Associate professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Director, Glenn Family Breast Center
Winship Cancer Institute of Emory University - Implication of GSTM1 Expression in Racial Survival Disparities in Head and Neck Cancer
Yong Teng, PhD
Associate professor, Department of Hematology and Medical Oncology
Emory University School of Medicine - Targeting Homologous Recombination Deficiency in Breast Cancer Treatment
Yong Wan, PhD
SOM Endowed Professor, Department of Pharmacology and Chemical Biology
Professor, Department of Hematology and Oncology
Emory University School of Medicine
Director for basic research, Glenn Family Breast Center
Winship Cancer Institute of Emory University